Literature DB >> 9607529

Prospective randomized trial of systemic antibiotics in patients undergoing liver resection.

C C Wu1, D C Yeh, M C Lin, T J Liu, F K P'eng.   

Abstract

BACKGROUND: Systemic antibiotics are administered frequently after hepatectomy to prevent infective complications, but their effectiveness is uncertain.
METHODS: A total of 127 patients with liver tumours were prospectively randomized into two groups after hepatectomy: in group 1 (62 patients) no antibiotics were given until the appearance of infective complications; in group 2 (65 patients) intravenous cephazolin 1 g every 6 h and gentamicin 80 mg every 8 h were given for 7 days. On the day before surgery all patients received bowel preparation by clear liquid diet and oral antibiotics (neomycin 1 g and erythromycin 1 g, given together in three doses).
RESULTS: The infective complication rate was 23 per cent in both groups (P = 0.95). The hospital costs were higher in group 2 (P < 0.001). Of the group 1 patients, 51 (82 per cent) did not require antibiotic treatment. No patient in either group died after hepatectomy.
CONCLUSION: Postoperative systemic antibiotics cannot prevent infective complications, and their routine use after hepatectomy is unnecessary and costly. The use of antibiotics should be delayed until infective complications and persistent septic symptoms occur.

Entities:  

Mesh:

Year:  1998        PMID: 9607529     DOI: 10.1046/j.1365-2168.1998.00606.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  12 in total

Review 1.  Small for size liver remnant following resection: prevention and management.

Authors:  Rony Eshkenazy; Yael Dreznik; Eylon Lahat; Barak Bar Zakai; Alex Zendel; Arie Ariche
Journal:  Hepatobiliary Surg Nutr       Date:  2014-10       Impact factor: 7.293

2.  Prospective randomized controlled trial investigating the type of sutures used during hepatectomy.

Authors:  Norifumi Harimoto; Ken Shirabe; Tomoyuki Abe; Takafumi Yukaya; Eiji Tsujita; Tomonobu Gion; Kiyoshi Kajiyama; Takashi Nagaie
Journal:  World J Gastroenterol       Date:  2011-05-14       Impact factor: 5.742

3.  Clinical prediction score for superficial surgical site infections: Real-life data from a retrospective single-centre analysis of 812 hepatectomies.

Authors:  Juwei Shen; Zuowei Ni; Yigang Qian; Bei Wang; Shusen Zheng
Journal:  Int Wound J       Date:  2019-10-23       Impact factor: 3.315

4.  Preoperative Antibiotic Prophylaxis Does Not Reduce the Risk of Postoperative Infectious Complications in Patients Undergoing Elective Hepatectomy.

Authors:  Yan-Ming Zhou; Zhen-Yi Chen; Xiu-Dong Li; Dong-Hui Xu; Xu Su; Bin Li
Journal:  Dig Dis Sci       Date:  2015-12-29       Impact factor: 3.199

Review 5.  Routine Postoperative Antibiotic Prophylaxis Offers No Benefit after Hepatectomy-A Systematic Review and Meta-Analysis.

Authors:  Anastasia Murtha-Lemekhova; Juri Fuchs; Miriam Teroerde; Ute Chiriac; Rosa Klotz; Daniel Hornuss; Jan Larmann; Markus A Weigand; Katrin Hoffmann
Journal:  Antibiotics (Basel)       Date:  2022-05-12

6.  Impact of laparoscopic liver resection for hepatocellular carcinoma with F4-liver cirrhosis.

Authors:  Akishige Kanazawa; Tadashi Tsukamoto; Sadatoshi Shimizu; Shintaro Kodai; Sadaaki Yamazoe; Satoshi Yamamoto; Shoji Kubo
Journal:  Surg Endosc       Date:  2013-02-08       Impact factor: 4.584

7.  Reducing surgical site infections in hepatopancreatobiliary surgery.

Authors:  Eugene P Ceppa; Henry A Pitt; Michael G House; E Molly Kilbane; Attila Nakeeb; C Max Schmidt; Nicholas J Zyromski; Keith D Lillemoe
Journal:  HPB (Oxford)       Date:  2012-11-05       Impact factor: 3.647

8.  Risk factors of surgical site infection after hepatectomy for liver cancers.

Authors:  Shin Kobayashi; Naoto Gotohda; Toshio Nakagohri; Shinichiro Takahashi; Masaru Konishi; Taira Kinoshita
Journal:  World J Surg       Date:  2009-02       Impact factor: 3.282

9.  Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial.

Authors:  Oriana Ciacio; Thibault Voron; Gabriella Pittau; Maité Lewin; Eric Vibert; René Adam; Antonio Sa Cunha; Daniel Cherqui; Astrid Schielke; Olivier Soubrane; Olivier Scatton; Chady Salloum; Daniel Azoulay; Stéphane Benoist; Perrine Goyer; Jean-Christophe Vaillant; Laurent Hannoun; Emmanuel Boleslawski; Hélène Agostini; Didier Samuel; Denis Castaing
Journal:  BMC Cancer       Date:  2014-12-18       Impact factor: 4.430

10.  Single Dose Based Ertapenem Prophylaxis Reduces Surgical Site Infection after Selective Hepatectomy of Hepatocellular Carcinoma: A Propensity Score Matching Study.

Authors:  Bin Tang; Xiaolin Liu; Fei Xing; Chao Wang; Changjun Jia; Songlin Peng; Yang Zhao; Chaoliu Dai; Feng Xu
Journal:  Biomed Res Int       Date:  2018-08-30       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.